Saluda Medical

Developer of neuromodulation platform measuring biomarkers for chronic neurological condition treatment

placeBloomington, Minnesota, United States calendar_todayFounded 2010 groups327 employees language saludamedical.com

Registered entities

Innovation

114 patent families (60 granted) — focus: Human necessities; filing pace steady. Cited 33,195 times.

YearFilings
201514
201620
201724
201819
201915
202032
202132
202236
202353
202444
202556
202626

Social engagement

Social engagement: 34.1K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

11 investors on record; lead investors include Boston Scientific, Redmile Group, Action Potential Venture Capital, BioScience Managers.

Investor typeCountShare
Venture capital218%
Private equity218%
Other / undisclosed764%

Hiring activity

Hires occasionally

2 roles tracked across 2 of the last 12 months

10 Apr 2026 · Post-Market Quality Specialist · Minneapolis

31 Mar 2026 · Senior Territory Manager - Pittsburgh, PA · Pittsburgh

7 Oct 2025 · Clinical Specialist - Virginia Beach, VA · Virginia Beach

Based on job postings tracked across public sources.

Recent activity

30 Jun 2026
Product launch
CAP24TM surgical paddle lead
26 Jun 2026
Event
ASPN Saluda Medical Innovation Suite
25 Jun 2026
Event
Saturday Lunch Symposium: Objective by Design: Disrupting Pain With the Evoke® System
Coming soon